Preferred Label : tyrosine;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015140.pub2/full/fr
2025
United Kingdom
review of literature
french abstract
EGF Receptors
mutation
epidermal growth factor-urogastrone receptor site
due to
adjuvant, nos
neoplasm, malignant
epidermal growth factor
neoplasm staging
persons
carcinoma, non-small-cell lung
disease
"u" lymphocyte
small cell lung carcinoma
excision, nos
receptors, growth factor
tyrosine
receptor Protein-Tyrosine kinases
Tyrosine Kinase Inhibitors

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/utilisation-en-contexte-quebecois-des-inhibiteurs-de-la-tyrosine-kinase-du-recepteur-du-facteur-de-croissance-epidermique-egfr-pour-le-traitement-du-cancer-du-poumon.html
2022
Canada
technical report
Lung cancer
tyrosine
tyrosine
EGF Receptors
receptors, growth factor
epidermal growth factor-urogastrone receptor site
lung neoplasms
receptor Protein-Tyrosine kinases
epidermal growth factor
lung cancer
neoplasm, malignant

---
Nous contacter.
26/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.